Related Experiment Video
Updated: Dec 16, 2025

09:50
Real-time Quaking-induced Conversion Assay for Detection of CWD Prions in Fecal Material
Published on: September 29, 2017
14.2K
Update on chronic wasting disease (CWD) III
EFSA Journal. European Food Safety Authority
|July 7, 2020
Summary
European and North American chronic wasting disease (CWD) strains appear different, with potential strain diversity within Europe. Zoonotic potential and human risk from CWD remain unevaluated, necessitating careful food chain management.
Area of Science:
- Veterinary Medicine
- Prion Diseases
- Food Safety
Background:
- Chronic wasting disease (CWD) is a transmissible spongiform encephalopathy affecting cervids.
- Concerns exist regarding CWD strain variations between North America (NA) and Europe, and potential zoonotic implications.
- The European Food Safety Authority (EFSA) was requested to assess the current knowledge on CWD.
Purpose of the Study:
- To revise knowledge on CWD strain differences between NA and Europe, and within Europe.
- To review new evidence on the zoonotic potential of CWD.
- To identify risk factors for CWD spread in the EU and recommend risk mitigation strategies.
Main Methods:
- Review of existing scientific literature and data on CWD isolates and surveillance programs.
- Comparative analysis of CWD strains from NA and Europe.
- Assessment of available data on zoonotic potential and risk factors.
Main Results:
- Preliminary data suggest differences between European and NA CWD strains, with evidence of strain diversity in European cervids.
- Current data are insufficient to conclude on the implications of strain diversity on CWD transmissibility, pathogenesis, or prevalence.
- Zoonotic potential of CWD isolates from both continents cannot be determined; human risk via meat consumption is not directly assessable but exposure can occur.
- Risk factors for CWD spread are linked to infectivity accumulation in tissues and animal co-localization.
Conclusions:
- Further characterization of European CWD isolates is needed.
- The zoonotic potential of CWD remains unknown, requiring measures to minimize human exposure.
- Comprehensive risk factor assessment is crucial for managing CWD spread in the EU.
More Related Videos
Related Concept Videos
Chronic Pancreatitis II: Collaborative Care
206
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
206
Cystic Fibrosis: Management
342
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
342
Chronic Kidney Disease I: Introduction
441
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
441
Chronic Kidney Disease IV: Nursing Management
207
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
207
Chronic Kidney Disease II: Clinical Manifestations
437
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
437
Chronic Pancreatitis I: Introduction
581
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
581

